Molecular Diagnostics






New Test Predicts Potential Success of BCG Immunotherapy for Bladder Cancer
A laboratory test that measures the amount of IL2 secretion from CD4+ T cells after overnight in vitro incubation with tuberculin predicts the potential success of BCG (Bacille Calmette-Guérin) immunotherapy treatment for bladder cancer. More...03 Sep 2018

In Other News
Multi-Omics Approach Guides Relapsed Multiple Myeloma Treatment
Whole-Genome Sequencing Diagnoses Early Infantile Epileptic Encephalopathy
DNA Screening and Invasive Testing Show Similar Miscarriage Rates
Improved Myeloma Diagnosis Based on Blood Count Components
ELISA kit Offers Enhanced Diagnosis of Zika Virus Infection
Genotyping Assay Integrated into Glioma Treatment
Blood-Based Test Predicts Benefits of Lung Cancer Treatment
Genetic Mutation Identified in Childhood Brain Disorder
Biomarker-Based Blood Test Developed for Early Cancer Diagnosis
Genetic Testing for Hypercholesterolemia Improves Diagnosis
Epigenetic Diagnostic Tool Detects Diseases in Newborns
New Glioma Test Provides Answers during Surgical Procedures
Gene Test Distinguishes Kawasaki Disease from Other Illnesses
Urine Test Accurately Detects Bladder Cancer Recurrence
FDA Clears Diagnostic Assay for Group B Strep
Infections Defined in Urothelial Bladder Tumors
Fracture Risk Predicted with New Genetic Screen
Susceptible Genes Identified for Childhood Kidney Disease
Mutations Identified As Cause for Rare Bone Marrow Disorder
New Troponin Assays Receive US Marketing Clearance
MicroRNA Panel Delivers Thyroid Cancer Diagnosis
Genetic Alterations Correlated to Aggressive Prostate Cancer
DNA Methylation Linked to Depression in Middle-Aged and Elderly
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.